science wire

« BACK

Pharmacology



Results 351 - 400 of 2594.
« Previous 1 ... 4 5 6 7 8 9 10 11 12 ... 52 Next »


Health - Pharmacology - 26.02.2021
EMA issues advice on casirivimab and imdevimab antibody cocktail for the treatment of mild-to-moderate COVID-19
CHMP has completed a review of available data for investigational antibody cocktail casirivimab and imdevimab (REGN-COV2) to be considered for the treatment of confirmed COVID-19 CHMP scientific op

Health - Pharmacology - 26.02.2021
Single dose of Pfizer BioNTech vaccine reduces asymptomatic infections and potential for SARS-CoV-2 transmission
Single dose of Pfizer BioNTech vaccine reduces asymptomatic infections and potential for SARS-CoV-2 transmission
New data from Addenbrooke's Hospital in Cambridge suggests that a single dose of the Pfizer BioNTech vaccine can reduce by four-fold the number of asymptomatic SARS-CoV-2 infections.

Pharmacology - Health - 26.02.2021
Novartis Cosentyx gains EU label update for first-of-its-kind MAXIMISE data in axial manifestations of psoriatic arthritis
Cosentyx (secukinumab) is the first biologic with proven efficacy in all 6 key manifestations of psoriatic arthritis (PsA), and the only biologic with fast and lasting relief of axial manifestations of PsA in a dedicated trial 1,2 ,3 .

Pharmacology - Chemistry - 26.02.2021
Cerium sidelines silver to make drug precursor
Cerium sidelines silver to make drug precursor
Rice lab's process simplifies fluoroketone synthesis Save your silver! It's better used for jewelry than as a catalyst for drugs. Rice University scientists have developed a greatly simplified method to make fluoroketones , precursors for drug design and manufacture that typically require a silver catalyst.

Health - Pharmacology - 26.02.2021
Common vaccine terms and definitions: U-M experts discuss
FACULTY Q&A Throughout the pandemic, we've been bombarded with terms like vaccine schedule, variants, mRNA, and more.

Health - Pharmacology - 25.02.2021
Roche announces results from Evrysdi (risdiplam) study in infants with Type 1 spinal muscular atrophy (SMA) published in New England Journal of Medicine
FIREFISH Part 1 data show treatment with Evrysdi at 12 months helped 90% of these infants survive without permanent ventilation and 33% sit without support, a key motor milestone not normally seen in

Pharmacology - 24.02.2021
Older people often incorrectly assume medicines don’t have potential side effects
FINDINGS Older people correctly ascertained basic information such as dosage and duration of use for more than 70% of the medications they were prescribed, regardless of whether their physician explained it during an office visit.

Pharmacology - Health - 23.02.2021
X-factor to help antibiotics regain their spark
Holding off the rise of superbugs could be achieved by 'resuscitating' old antibiotics, with The University of Queensland researchers leading an international project to help combat the growing threat.

Health - Pharmacology - 19.02.2021
Global taskforce set to demystify and overcome vaccine hesitancy amid COVID-19 pandemic
International experts are joining forces to combat vaccine hesitancy by tackling its root cause - misinformation - and arming key influencers with the facts.

Health - Pharmacology - 18.02.2021
Major 2.2m research project aims to improve treatment and understanding of Long COVID
Major 2.2m research project aims to improve treatment and understanding of Long COVID
The University of Birmingham today launches a major new 2.2m government-funded research project to improve the treatment, causes and symptoms of so-called Long COVID in non-hospitalised patients.

Pharmacology - Health - 17.02.2021
New Grant Funds Clinical Trial to Assess Psychedelic as Treatment for Phantom Limb Pain
Steven & Alexandra Cohen Foundation awards $1.3 million to investigate therapeutic potential of psilocybin, the active compound in "magic mushrooms" The Psychedelics and Health Research Initia

Pharmacology - Health - 17.02.2021
Improving a Vaccine Delivery System for COVID and Beyond
Researchers at Carnegie Mellon University's College of Engineering and the University of Pittsburgh's School of Medicine have been awarded a grant from the Richard King Mellon Foundation to develop a

Pharmacology - Health - 16.02.2021
Novartis Entresto granted expanded indication in chronic heart failure by FDA
Entresto is the first and only therapy approved in the US to treat patients diagnosed with guideline-defined heart failure to include both those with heart failure with reduced ejection fraction (HFr

Pharmacology - Health - 15.02.2021
Information is Key to Vaccination Willingness
Information is Key to Vaccination Willingness
In Germany, the willingness to receive a vaccination has risen slightly from 57 to 62 percent since November.

Health - Pharmacology - 15.02.2021
UofG announces research collaboration with Lilly to discover potential new drug targets
The University of Glasgow has entered into a research collaboration with pharmaceutical company Eli Lilly and Company, that aims to discover and validate the next generation of drug targets for immunological diseases.

Pharmacology - Health - 11.02.2021
Mexico’s poor have little luck obtaining opioids intended for palliative care
If you're poor and terminally ill in southern Mexico, there's far less chance you'll get the painkillers you need for palliative care than your cousins in more prosperous regions, particularly those pharmacy-rich areas along Mexico-U.S. border, say UCLA researchers and colleagues who studied opioid dispensing levels across the country.

Health - Pharmacology - 11.02.2021
Opinion: Poor support for self-isolation undermines the UK’s Covid vaccination effort
The more that Covid-19 is allowed to replicate in the community, the greater the risk of mutations that escape the vaccines, argues Professor Anthony Costello (UCL Institute for Global Health).

Health - Pharmacology - 10.02.2021
A very aggressive cancer defeated in three months
A very aggressive cancer defeated in three months
A team from the University of Geneva and HUG managed to save a woman whose aggressive cancer left her with only five months to live.

Pharmacology - Health - 10.02.2021
The COVID-19 vaccines are safe and 7 other things you should know
People should get vaccinated. That's the message experts from UCLA Health want everyone to know. The two current vaccines against COVID-19 have been tested and approved by the U.S Food and Drug Administration and have been shown to be both safe and highly effective.

Health - Pharmacology - 10.02.2021
Drug trial that could improve respiratory recovery from COVID-19 now underway
A clinical trial has commenced this week to test whether a drug called Almitrine can help people who are seriously ill with COVID-19 to recover from the disease.

Health - Pharmacology - 09.02.2021
Common asthma treatment reduces need for hospitalisation in COVID-19 patients
A team of medical research and statistical modelling experts at Oxford University and the Alan Turing Institute have conducted a joint analysis to assess the impact of the NHS COVID-19 contact tracing app. The research suggests the app stopped between 200,000 and 900,000 infections between 1st October and 31st December 2020, when 1.9 million people were infected with coronavirus in England and Wales.

Pharmacology - Health - 09.02.2021
Irrational Fears of Life-Threatening
Irrational Fears of Life-Threatening "corona" Virus Diagnosis
Recent results (05.02.21) of the study "Knowledge of and attitudes towards Corona", initiated by Univ.-Prof. Manuel Schabus, includes data from a total of 3,606 adults living in Austria (64.2% female, 35.5% male, 0.3% diverse).

Health - Pharmacology - 08.02.2021
Australia must stop hoarding its COVID-19 vaccines
Australia must stop hoarding its COVID-19 vaccines
The most at-risk Australians should be vaccinated against COVID-19 now, but the rest of the country can wait, according to an infectious diseases specialist and an ethics expert at The Australian National University (ANU).

Pharmacology - Health - 08.02.2021
Novartis receives FDA Breakthrough Therapy designations for investigational STAMP inhibitor asciminib (ABL001) in chronic myeloid leukemia
Designation in patients with chronic myeloid leukemia (CML) resistant or intolerant to prior treatments based on positive data from pivotal Phase III ASCEMBL trial evaluating asciminib, an investigat

Pharmacology - Health - 05.02.2021
How were researchers able to develop COVID-19 vaccines so quickly?
Vaccine development is typically measured in years, not months. But as the COVID-19 pandemic rages on, scientists are are racing the clock-and breaking records-to develop an immunization that provides protection against the virus. The nation's scientific community also faces another obstacle: convincing the public that the COVID-19 vaccine is safe, and how important it is to get a COVID-19 vaccination in the first place.

Health - Pharmacology - 05.02.2021
HIV/AIDS researcher David Katzenstein dies
The Stanford virologist conducted clinical vaccine trials, which led to the approval of antiretroviral drugs, greatly improving the survival of people living with HIV David Katzenstein, MD, professor

Health - Pharmacology - 04.02.2021
New education resources launched to mark World Cancer Day and inspire next generation of researchers
Cardiff University has teamed up with the Wales Cancer Research Centre to launch a competition and education pack to mark World Cancer Day.

Health - Pharmacology - 02.02.2021
Analysis: Egg freezing is on the up - but new research raises questions about how clinics advertise
Dr Zeynep Gurtin (UCL EGA Institute for Women's Health) discusses her analysis of the UK's 15 largest fertility clinics which offer egg freezing, warning that in general they provide a poor standard of information.

Health - Pharmacology - 01.02.2021

Pharmacology - Health - 01.02.2021
Belief in Covid conspiracies linked with vaccine hesitancy
Low likelihood of accepting a coronavirus vaccine is associated with having "conspiracy suspicions" about the pandemic, a new study led by by the University of Bristol and King's College London has found.

Health - Pharmacology - 01.02.2021
New partnership announced with med-tech company Aparito
The University of Birmingham has today announced a partnership with med-tech company Aparito to co-develop digital platforms to assess patient quality of life and symptoms in clinical trials and routine NHS care.

Health - Pharmacology - 01.02.2021
African and Hispanic Americans Report Low Rates of COVID-19 Vaccinations
Daily national surveys by Carnegie Mellon University show Black and Hispanic Americans are far less likely than whites to report that they have received COVID-19 vaccinations. Just 6.4% of African Americans and 6.8% of Hispanic Americans say they have received the vaccines, compared to 9.3% of whites.
« Previous 1 ... 4 5 6 7 8 9 10 11 12 ... 52 Next »